Awbat Versus Biobrane in Partial Thickness Burns
Launched by THE UNIVERSITY OF TEXAS MEDICAL BRANCH, GALVESTON · Feb 18, 2009
Trial Information
Current as of May 29, 2025
Withdrawn
Keywords
ClinConnect Summary
Currently there is no "best covering" or a standard "approved care" for treating partial thickness burns. Several options are available; however, they all have shortcomings. The application of topical antimicrobial dressings is time consuming and the regular dressing changes often associated with pain. Homograft or cadaver skin is often unavailable or in great shortage for skin transplants. Biobrane®, a biosynthetic wound dressing constructed of a silicone film with a nylon fabric partially imbedded into the film, has been available and used at our institute for many years as a skin substit...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Partial thickness burns between 4% and 40% Total Body Surface Area(TBSA)
- • Full thickness burns not to exceed 10% TBSA,
- • Age as specified
- Exclusion Criteria:
- • Full thickness burns that require immediate excision and grafting
- • Known allergic reaction against Biobrane
- • Chemical and electrical burns
About The University Of Texas Medical Branch, Galveston
The University of Texas Medical Branch (UTMB) in Galveston is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. As a prominent sponsor of clinical trials, UTMB leverages its extensive resources, multidisciplinary expertise, and commitment to excellence to facilitate groundbreaking studies that address critical health challenges. With a focus on translating scientific discoveries into effective therapies, UTMB fosters collaboration among researchers, clinicians, and participants to enhance patient outcomes and contribute to the overall advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Galveston, Texas, United States
Patients applied
Trial Officials
David N Herndon, MD
Principal Investigator
Shriners Hospital for Children and University of Texas Medical Branch
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials